Riskpilot← Back to searchSign inGet full accessOusia Pharma ApS
APSActiveCVR 43055909Ole Maaløes Vej 3Research and experimental development on natural sciences and engineering · NACE 7210Est. 20228 employees
Revenue 2024
DKK -3,7M
+63% vs 2023
EBITDA margin
155.1%
-32% vs 2023
Equity ratio
-198.2%
Financial strength
Net profit 2024
DKK -5,3M
-43% vs 2023
| Revenue | DKK -3,7M | +63% |
| EBITDA | DKK -5,7M | -32% |
| Net profit | DKK -5,3M | -43% |
| Total assets | DKK 5,1M | -12% |
| Equity | DKK -10,1M | -113% |
| Employees | 8 | — |
Legal name
Ousia Pharma ApS
CVR number
43055909
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
14. februar 2022
Share capital
DKK 61.897
Employees
8 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsesformanden sammen med to bestyrelsesmedlemmer eller af den samlede bestyrelse i forening.
Company purpose
Formål er at udvikle nye lægemiddelkandidater til behandling af kroniske sygdomme.
Address
Ole Maaløes Vej 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | -645 | -2.240 | -3.656 |
| Staff expenses | -450 | -2.064 | -2.016 |
| EBITDA | -1.095 | -4.304 | -5.672 |
| Depreciation & amort. | -0 | -0 | -0 |
| EBIT | -1.095 | -4.304 | -5.672 |
| Net financials | -110 | -232 | -510 |
| Profit before tax | -1.205 | -4.536 | -6.181 |
| Tax | -301 | -789 | -833 |
| Net profit | -904 | -3.747 | -5.349 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 3.280 | 5.798 | 5.090 |
| Equity | -864 | -4.738 | -10.087 |
| Long-term debt | 4.090 | 10.314 | 10.841 |
| Short-term debt | 54 | 223 | 4.336 |
| Total debt | 4.144 | 10.537 | 15.177 |
EBITDA margin
-567194400.0%
This company
15.8%
Market median
-3589838075% vs market
20222024
Equity ratio
-198.2%
This company
38.2%
Market median
-619% vs market
20222024
Return on equity
-534857900.0%
This company
18.4%
Market median
-2906836513% vs market
20222024
Net profit margin
-534857900.0%
This company
8.1%
Market median
-6603184051% vs market
20222024
Asset turnover
-0.72×
This company
1.12×
Market median
-164% vs market
20222024
Debt / equity
1.50×
This company
0.62×
Market median
-142% vs market
20222024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-02-14 – 2022-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CC Management | Management | 2022 | — | — |
AB Management | Management | 2022 | — | — |
JO Management | Management | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 15.0% | 15.0% | 2025 | |
Nordic Alchemy Holding ApS | Company | 15.0% | 15.0% | 2025 |
Klein Science Holding ApS | Company | 15.0% | 15.0% | 2025 |
Science Studio Holding ApS | Company | 15.0% | 15.0% | 2025 |
BII Holdings A/S | Company | 10.0% | 10.0% | 2025 |
BioInnovation Institute Fonden | Company | 10.0% | 10.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BioInnovation Institute Fonden
Ousia Pharma ApS Board members of Ousia Pharma ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christoffer Clemmensen | Management | 0 companies |
| Anders Bue Klein | Management | 0 companies |
| Jonas Odgaard Petersen | Management | 0 companies |
| Margareta Elisabeth Björk | Board of Directors | 0 companies |
| Morten Peltola Toft | Board of Directors | 0 companies |
| Jeppe Ragnar Andersen | Board of Directors | 0 companies |
| Mikael Søndergaard Thomsen | Board of Directors | 0 companies |
| Ian Rodney Laquian | Chairman | 0 companies |
| Otello Stampacchia | Board of Directors | 0 companies |
| Menelas Nicolas Pangalos | Board of Directors | 0 companies |